Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 5;5(1):19.
doi: 10.3390/medicines5010019.

Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology

Mario Ganau  1   2 , Nikolaos Syrmos  3 , Marco Paris  4 , Laura Ganau  5 , Gianfranco K I Ligarotti  6 , Ali Moghaddamjou  7 , Salvatore Chibbaro  8 , Andrea Soddu  9 , Rossano Ambu  10 , Lara Prisco  11
Affiliations
Review

Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology

Mario Ganau et al. Medicines (Basel). .

Abstract

This systematic review aims to summarize the impact of nanotechnology and biomedical engineering in defining clinically meaningful predictive biomarkers in patients with traumatic brain injury (TBI), a critical worldwide health problem with an estimated 10 billion people affected annually worldwide. Data were collected through a review of the existing English literature performed on Scopus, MEDLINE, MEDLINE in Process, EMBASE, and/or Cochrane Central Register of Controlled Trials. Only experimental articles revolving around the management of TBI, in which the role of new devices based on innovative discoveries coming from the field of nanotechnology and biomedical engineering were highlighted, have been included and analyzed in this study. Based on theresults gathered from this research on innovative methods for genomics, epigenomics, and proteomics, their future application in this field seems promising. Despite the outstanding technical challenges of identifying reliable biosignatures for TBI and the mixed nature of studies herein described (single cells proteomics, biofilms, sensors, etc.), the clinical implementation of those discoveries will allow us to gain confidence in the use of advanced neuromonitoring modalities with a potential dramatic improvement in the management of those patients.

Keywords: biomarkers; mass spectroscopy; microRNA; proteomics; traumatic brain injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Selection process of suitable articles to be analyzed in this systematic review.
See this image and copyright information in PMC

References

    1. Prisco L., Iscra F., Ganau M., Berlot G. Early predictive factors on mortality in head injured patients: A retrospective analysis of 112 traumatic brain injured patients. J. Neurosurg. Sci. 2012;56:131–136. - PubMed
    1. Ganau M., Prisco L. Comment on “neuromonitoring in traumatic brain injury”. Minerva Anestesiol. 2013;79:310–311. - PubMed
    1. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Coronado V.G., McGuire L.C., Sarmiento K., Bell J., Lionbarger M.R., Jones C.D., Geller A.I., Khoury N., Xu L. Trends in Traumatic Brain Injury in the U.S. and the public health response: 1995–2009. J. Saf. Res. 2012;43:299–307. doi: 10.1016/j.jsr.2012.08.011. - DOI - PubMed
    1. Syrmos N., Ganau M., De Carlo A., Prisco L., Ganau L., Valadakis V., Grigoriou K., Iliadis C., Arvanitakis D. Dealing with the surgical and medical challenges of penetrating brain injuries. Case Rep. Surg. 2013;2013:209750. doi: 10.1155/2013/209750. - DOI - PMC - PubMed

LinkOut - more resources